Respiratory syncytial virus infection: an innate perspective
Related Experiment Video
Updated: Mar 8, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
1Respiratory Infections Section, St Mary's campus, National Heart and Lung Institute, Imperial College London, London, W2 1PG, UK.
Insights
Respiratory syncytial virus (RSV) causes severe illness in infants, often due to immune system overreactions. Understanding this immune response is key to preventing severe RSV disease and hospitalizations.
Area of Science:
- Immunology
- Virology
- Pediatrics
Background:
- Respiratory syncytial virus (RSV) is a leading cause of infant hospitalizations and severe lower respiratory tract infections.
- While risk factors like prematurity exist, severe RSV disease can affect healthy infants.
- The precise mechanisms driving severe RSV disease remain unclear, but immune system dysregulation is suspected.
Purpose of the Study:
- To review recent findings on the immune response during RSV infection.
- To explore the balance between effective viral clearance and immunopathology.
- To understand factors contributing to severe RSV disease in infants and adults.
Main Methods:
- Literature review of recent discoveries in RSV immunology.
- Analysis of immune cell recruitment and activation pathways.
- Examination of host-pathogen interactions in RSV infection.
Main Results:
- RSV infection can trigger an excessive immune response, leading to tissue damage.
- Both innate and adaptive immune cells play a role in RSV immunopathology.
- The immune system's dual role in clearing the virus while potentially causing harm is highlighted.
Conclusions:
- Dysregulated immune responses contribute significantly to severe RSV disease.
- Further research into immune modulation could lead to better treatments for RSV.
- Balancing immune clearance and preventing immunopathology is crucial for managing RSV infections.
Abstract:
Respiratory syncytial virus (RSV) is a common cause of upper respiratory tract infection in children and adults. However, infection with this virus sometimes leads to severe lower respiratory disease and is the major cause of infant hospitalisations in the developed world. Several risk factors such as baby prematurity and congenital heart disease are known to predispose towards severe disease but previously healthy, full-term infants can also develop bronchiolitis and viral pneumonia during RSV infection. The causes of severe disease are not fully understood but may include dysregulation of the immune response to the virus, resulting in excessive recruitment and activation of innate and adaptive immune cells that can cause damage. This review highlights recent discoveries on the balancing act of immune-mediated virus clearance versus immunopathology during RSV infection.
Related Concept Videos
Pneumonia II: Pathophysiology
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Introduction to Innate and Adaptive Immunity
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

